Prasol Chemicals Limited
Open now8–10 Sep 2026
Updated 2026-09-08 (IST)
What Prasol Chemicals Limited does
A forward integrated manufacturer of acetone and phosphorous based specialty chemicals and other specialty chemicals involving complex and differentiated chemistries.
Prasol Chemicals Limited financials
Rs crore · AnnualLatest year highlighted in green. Sparklines show the trend.
| FY24 | FY25 | FY26 | ||
|---|---|---|---|---|
| Sales | 877 | 1,012 | 1,233 | |
| Operating Profit | 61 | 88 | 139 | |
| OPM % | 6.9% | 8.7% | 11.3% | |
| Net Profit | 18 | 44 | 83 | |
| Total Debt | 82 | 101 | 110 |
Prasol Chemicals Limited IPO offer structure
Total: ₹500 cr. Fresh issue proceeds go to the company; OFS proceeds go to selling shareholders.
Issue size and split come from a public aggregator rather than the exchange, cross-checked against a second one. The offer document states the offer-for-sale as a share count against a blank amount, so it cannot be read from the document itself.
Use of proceeds- Repayment and/ or pre-payment, in full or part, of certain borrowings availed by our Company: ₹60 cr
- General corporate purposes
Prasol Chemicals Limited promoters and holding
- NISHITH RAJNIKANT SHAH: Chairman and Whole-time Director
- GAURANG NATWARLAL PARIKH: Managing Director
- DHAVAL NALIN PARIKH: Joint Managing Director
- PANKIL NISHITH DHARIA: Whole-time Director – Strategy and Business Development
- SACHIN JATIN PARIKH: Promoter
Prasol Chemicals Limited strengths and risks
Company-stated strengths and disclosed risk factors from the offer document.
- Highly diversified product portfolio used across various Application Industries. (p.203)
- Well established R&D capabilities driving innovation with strong pipeline of products to address customised customer requirements. (p.203)
- Long standing relationships with a diversified customer base and strong global presence. (p.204)
- Experienced, Qualified and Professional Leadership Team with a focus on business sustainability. (p.205)
- Robust financial performance. (p.205)
- Our business is dependent on our manufacturing facilities and we are subject to certain related risks. (p.25)
- Some of the raw materials that we use, certain byproducts that are generated, as well as our finished products are hazardous, corrosive and flammable. (p.25)
- There are outstanding litigations involving our Company, Promoters and Directors. (p.25)
- Our net cash from operating activities has significantly moved in the past. (p.25)
- The Deputy Director, Industrial Safety & Health, Raigad District has issued show cause notices against Gaurang Natwarlal Parikh. (p.25)
Prasol Chemicals Limited peer comparison: DRHP median P/E 42.7x
Live BSE prices| Company | CMP | P/E | OPM% | ROE% | Source |
|---|---|---|---|---|---|
| Aarti Industries Limited | Rs 491.05 -0.2% | 33.6x | 16.5% | 9.6% | live |
| Atul Limited | Rs 6,309.15 -1.2% | 22.9x | 20.3% | 12.6% | live |
| Laxmi Organic Industries Limited | Rs 172.05 | 38.0x | 11.5% | 6.2% | live |
| Vinati Organic Limited | Rs 1,298.8 -0.9% | 30.0x | 27.3% | 19.3% | live |
| Privi Speciality Chemicals Limited | Rs 3,377.5 +0.3% | 38.6x | 26.7% | 37.6% | live |
| Yasho Industries Limited | Rs 3,992.4 -3.4% | 83.5x | 23.6% | 17.7% | live |
| Excel Industries Limited | Rs 1,001.45 -2.7% | 17.6x | 16.6% | 8.2% | live |
P/E from offer document where live data unavailable. Not a fair-value judgement.
Prasol Chemicals Limited market and competition
According to the CARE Report, during the calendar years 2022-2025, we were the largest importer of acetone in India to produce the most diversified range of acetone-based specialty chemicals in India. We compete with manufacturers such as Arkema, Evonik, TASCO, Solvay in acetone based specialty chemicals and Hubei Xingfa, Liaoning Ruixing, Excel industries in phosphorous derivatives.
Prasol Chemicals Limited outlook, as the document states it
Our current growth strategies include debottlenecking and expanding our production capacities for existing product portfolio, increasing focus on R&D to support complex chemistries, product innovation, import substitution, and forward and backward integration of existing products, and pursuing inorganic growth through strategic acquisitions, technology acquisition/licensing or joint ventures.
Never miss an IPO like this
Every upcoming IPO analysed: subscription, GMP and a DRHP breakdown, in your inbox, free. One email when each one opens.
Prasol Chemicals Limited IPO: common questions
When does the Prasol Chemicals Limited IPO open and close?
The Prasol Chemicals Limited IPO is open from 8 Sep 2026 to 10 Sep 2026.
What is the Prasol Chemicals Limited IPO price band?
The price band is ₹643–₹676 per share.
What is the lot size and minimum investment for the Prasol Chemicals Limited IPO?
One lot is 22 shares, and a retail application must be at least one lot. That is about ₹14,872 at the upper end of the band. An HNI application starts above Rs 2 lakh, so the minimum is higher for that category.
What is the grey-market premium (GMP) for the Prasol Chemicals Limited IPO?
As of 8 Sep 2026 the indicative GMP is +8.1%. GMP is unregulated and self-reported. Never decide on it alone.
When are the Prasol Chemicals Limited IPO allotment and listing dates?
Not published yet. Derived from the close date on the usual timetable: allotment around 11 Sep 2026, refund/unblock around 14 Sep 2026 and listing around 16 Sep 2026. Treat these as estimates until the exchange confirms them.
How do I apply for the Prasol Chemicals Limited IPO?
Through any broker app or your bank's net banking, using a demat account and a PAN. You bid in lots at a price inside the band, or at cut-off. The money is blocked in your account, not debited, until allotment. One application per PAN. We do not recommend brokers and carry no broker links. How to apply, start to finish →
Sources & method
Subscription and issue data come from the NSE and BSE exchange feeds, with the third-party aggregator, clearly labelled, where an exchange feed is unreachable. DRHP analysis is extracted from the offer document itself, every figure cited to its page. Each figure on the page carries its source and its timestamp.
Grey-market premium (GMP) is unregulated.
Every GMP figure is a self-reported grey-market estimate. No exchange, regulator or clearing body records or audits it, and there is no settlement guarantee or recourse. Shown for context only; never decide on GMP alone. New to GMP? The 30-second explainer → Has GMP actually been right? →
How often do these actually open above the issue price?
Of the 505 mainboard IPOs that have listed on the NSE since 2003, 359 (71%) opened above their issue price, at a median of +10%. That is the segment's own record, not a forecast for this issue.